Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 30.50
-1.20 (-3.79%)
At close: Apr 17, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 4.6 billion as of April 17, 2026. Its market cap has decreased by -8.27% in one year.
Market Cap
4.60B
Enterprise Value
3.19B
Revenue
9.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.50
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 4.60B, a decrease of -16.80%. That is a compound annual growth rate of -3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.60B | 15.53% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Steminent Biotherapeutics | 5.69B |
| Panion & Bf Biotech | 5.53B |
| UnicoCell Biomed | 5.17B |
| OBI Pharma | 4.99B |
| Senhwa Biosciences | 4.88B |
| Pharmosa Biopharm | 4.76B |
| Medigen Biotechnology | 4.25B |
| Sagittarius Life Science | 4.19B |